About: Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published in The Journal of the American Medical Association

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1998 (uk) im Juni 1998 veröffentlichter wissenschaftlicher Artikel (de) article publié dans la revue scientifique Journal of the American Medical Association (fr) scientific article published in The Journal of the American Medical Association (en)
publication date	wds:Q59700719-D9E42AF3-A806-46A4-B7DE-DA221509638B
publication date	1998-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59700719-4855673D-19AA-40E3-B825-6EAEFCDB0F99
language of work or name	English
author name string	wds:Q59700719-3B927CC4-6409-4E04-853D-0543BAA12C6F wds:Q59700719-7847B78B-A471-488F-99F8-E643A98BA409
author name string	M A Wainberg G Friedland
rdfs:label	Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (en) Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (nl)
skos:prefLabel	Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (en) Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (nl)
name	Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (en) Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance (nl)
title	wds:Q59700719-C556DC6E-E119-43A0-89A6-54E4D8597BDC
title	Public health implications of antiretroviral therapy and HIV drug resistance (en)
page(s)	wds:Q59700719-E36ED4A5-D734-4B15-9BD2-F009BB68A1D8
page(s)	1977-1983
instance of	wds:Q59700719-0E27D96C-8B05-4A6A-AD41-991C7B3E79D8
instance of	scholarly article
main subject	wds:Q59700719-0A6FB817-2237-4510-B4A5-48F485A38F51
main subject	HIV
PubMed ID	wds:Q59700719-198E8A54-F5E1-42F9-99B9-40836162DD48
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9643862
PubMed ID	9643862
published in	wds:Q59700719-E11EF8AB-195F-4D4F-8495-E93123A580E5
published in	The Journal of the American Medical Association
issue	wds:Q59700719-8F1A6150-E3E9-4CD1-BC18-56817DA0498C
volume	wds:Q59700719-5071C04D-5F62-4C9D-9EB3-EE1772C76EF3
issue	24
volume	279
DOI	wds:Q59700719-938DC16A-6039-478F-BA98-59E15B993273
DOI	http://dx.doi.org/10.1001/JAMA.279.24.1977
DOI	10.1001/JAMA.279.24.1977
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59700719
is cites work of	Production of resistant HIV mutants during antiretroviral therapy Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis Patient adherence to HIV medication regimens: a review of published and abstract reports Is average adherence to HIV antiretroviral therapy enough? HIV-1 integrase inhibitory substances from Coleus parvifolius. Rates of transmission of antiretroviral drug resistant strains of HIV-1. HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand How well do clinicians estimate patients' adherence to combination antiretroviral therapy? Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. Use of an on-line pager system to increase adherence to antiretroviral medications Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse Development and validation of a measure for intention to adhere to HIV treatment The information-motivation-behavioral skills model of antiretroviral adherence and its applications Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. Trauma, dissociation, and antiretroviral adherence among persons living with HIV/AIDS. Adherence-resistance relationships to combination HIV antiretroviral therapy Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status Changes in sexual behavior among HIV-infected women after initiation of HAART Comorbid medical illness in psychiatric patients Taking antiretroviral therapy for HIV infection: learning from patients' stories Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte dʼIvoire Structural basis for activation of α-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men 4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Global dimensions of the AIDS epidemic: implications for prevention and care Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia Use of drug effect interaction modeling with Monte Carlo simulation to examine the impact of dosing interval on the projected antiviral activity of the combination of abacavir and amprenavir Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS A proposal for quality standards for measuring medication adherence in research Antiretroviral therapy for the prevention of HIV transmission: what will it take? A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Crystal Structure Flexible Cyclic Ethers/Polyethers as Novel P2-Ligands for HIV-1 Protease Inhibitors: Design, Synthesis, Biological Evaluation, and Protein−Ligand X-ray Studies † Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1′-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein−Ligand X-ray Studies ∞ Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection Study. Alcohol consumption and HIV disease progression: are they related? Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients Transmitted drug resistance in nonsubtype B HIV-1 infection When does overuse of antibiotics become a tragedy of the commons? A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs? Neurocognitive impairment and HIV risk factors: a reciprocal relationship Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software